females to follow finalist
RISING STAR IN industry
Andrea Sáez
Chief
Development Officer
Agomab
Therapeutics
About Andrea Sáez
Andrea Sáez is Chief Development Officer at Agomab Therapeutics, a clinical-stage Belgian company developing anti-fibrotic drugs. Prior to joining Agomab, she was CSO/COO at Origo Biopharma, a Spanish biotech sold to Agomab in 2021. Andrea had supported Origo since she was a Senior Associate at Asabys Partners, a VC firm which invested in Origo at their series seed. Andrea holds a PhD in Immunology and is experienced in regulatory affairs and R&D management through various previous positions in consultancy and biotech companies. Andrea has built a strong scientific background complemented by broad experience in regulatory, biotech and venture capital roles.
About Agomab
Therapeutics
Agomab is a biotech company developing novel treatments that aim to preserve and restore organ function in fibrotic diseases. By translating a deep expertise in growth factor biology, we pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. We combine our innovative R&D approach with an ambitious corporate strategy to develop a broad clinical pipeline of assets that target two key signaling pathways that are involved in fibrosis: transforming growth factor beta (TGFβ) and hepatocyte growth factor (HGF).
Agomab is a biotech company developing novel treatments that aim to preserve and restore organ function in fibrotic diseases. By translating a deep expertise in growth factor biology, we pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. We combine our innovative R&D approach with an ambitious corporate strategy to develop a broad clinical pipeline of assets that target two key signaling pathways that are involved in fibrosis: transforming growth factor beta (TGFβ) and hepatocyte growth factor (HGF).
| Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | | |
© Copyright 2020 by Hyphen Projects